ATE192040T1 - Wirkstoff gegen arteriosklerose - Google Patents

Wirkstoff gegen arteriosklerose

Info

Publication number
ATE192040T1
ATE192040T1 AT95909975T AT95909975T ATE192040T1 AT E192040 T1 ATE192040 T1 AT E192040T1 AT 95909975 T AT95909975 T AT 95909975T AT 95909975 T AT95909975 T AT 95909975T AT E192040 T1 ATE192040 T1 AT E192040T1
Authority
AT
Austria
Prior art keywords
active ingredients
proliferation
smooth muscle
muscle cells
arteriosclerosis
Prior art date
Application number
AT95909975T
Other languages
English (en)
Inventor
Hisao Tomioka
Hidefumi Ohsawa
Masao Moroi
T Kawashima
Original Assignee
Mitsubishi Tokyo Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Tokyo Pharm Inc filed Critical Mitsubishi Tokyo Pharm Inc
Application granted granted Critical
Publication of ATE192040T1 publication Critical patent/ATE192040T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT95909975T 1994-05-31 1995-02-24 Wirkstoff gegen arteriosklerose ATE192040T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11914694 1994-05-31
PCT/JP1995/000277 WO1995032714A1 (fr) 1994-05-31 1995-02-24 Depresseur de l'arteriosclerose

Publications (1)

Publication Number Publication Date
ATE192040T1 true ATE192040T1 (de) 2000-05-15

Family

ID=14754063

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95909975T ATE192040T1 (de) 1994-05-31 1995-02-24 Wirkstoff gegen arteriosklerose

Country Status (8)

Country Link
US (1) US5840741A (de)
EP (1) EP0766963B1 (de)
KR (1) KR970703147A (de)
AT (1) ATE192040T1 (de)
AU (1) AU702727B2 (de)
CA (1) CA2190750A1 (de)
DE (1) DE69516519T2 (de)
WO (1) WO1995032714A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100885007B1 (ko) * 2001-02-26 2009-02-20 미쓰비시 타나베 파마 코퍼레이션 신질환·신부전의 예방 또는 치료를 위한 약학 조성물
US20070225301A1 (en) * 2006-02-13 2007-09-27 Astion Inflammation Aps Treatment of acne and other diseases
KR20090106526A (ko) * 2006-12-18 2009-10-09 카르도스 아베 염증 질환 치료를 위한 새로운 조합
WO2008075028A1 (en) * 2006-12-20 2008-06-26 Cardoz Ab New combination for use in the treatment of inflammatory disorders
US20100184783A1 (en) * 2007-07-11 2010-07-22 Johan Raud Combination for use in the treatment of inflammatory atherosclerosis comprising a mast cell inhibitor and a ppar gamma agonist
WO2009007680A2 (en) 2007-07-11 2009-01-15 Cardoz Ab Combinations comprising a mast cell inhibitor and a statin for use in the treatment of inflammatory disorders
WO2009007679A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a thromboxane a2 antagonist
WO2009007675A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a p2 gamma 12 antagonist
DE102014222804B4 (de) 2014-11-07 2023-12-28 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Vorrichtung und Verfahren zum Bestimmen einer Wandschubspannung und System zur Erkennung von Arteriosklerose

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH9305A (en) * 1970-05-21 1975-08-18 H Hess Trialkoxy quinazolines
JP3116970B2 (ja) * 1991-06-12 2000-12-11 三菱東京製薬株式会社 ペミロラストカリウムの徐放性製剤

Also Published As

Publication number Publication date
KR970703147A (ko) 1997-07-03
WO1995032714A1 (fr) 1995-12-07
AU1823995A (en) 1995-12-21
EP0766963A4 (de) 1997-10-29
DE69516519T2 (de) 2000-10-12
EP0766963A1 (de) 1997-04-09
CA2190750A1 (en) 1995-12-07
DE69516519D1 (de) 2000-05-31
US5840741A (en) 1998-11-24
EP0766963B1 (de) 2000-04-26
AU702727B2 (en) 1999-03-04

Similar Documents

Publication Publication Date Title
ATE370138T1 (de) Neue imidazopyridine und ihre verwendung
MY107341A (en) Novel hydroxamic acid and n-hydroxyurea derivatives and their use
DE69410121D1 (en) Dihydro pyrazolopyrrole
TR199801642T2 (xx) Tedavide faydal� olan karbamik asitlerin azabisiklik esterleri.
HK1021699A1 (en) Pentafluorobenzenesulfonamides and analogs.
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
SE9604786D0 (sv) New compounds
TR199802060T2 (xx) Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�.
NZ513096A (en) Compositions for treating inflammatory response
ATE161531T1 (de) Acridine-1,8-dionderivate als therapeutisches mittel
TR199902495T2 (xx) Bile�imler.
ATE192040T1 (de) Wirkstoff gegen arteriosklerose
DE69223736D1 (de) Acridine-1,8-Dionderivate als therapeutisches Mittel
DE69519385D1 (de) Chinazolinon-arzneimittel sowie deren verwendung
ATE297926T1 (de) Hexahydropyrazino(1'2':1,6)-pyrido(3,4-b)indole 1,4-dion-derivate zur behandlung von cardiovaskulären erkrankungen und erektionsstörungen
DE69103773D1 (de) Derivate von hydroxaminsäure die lipoxygenase hemmen.
SE9802650D0 (sv) Compounds
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties